Connect with us

Bloomberg Technology

Novavax Could Deliver 100M Covid-19 Vaccine Doses By End of Year, Says R&D Head

May.14 — Novavax Inc.’s vaccine is one of at least 100 potential candidates trying to curb the spread of the virus that causes Covid-19. The biotech company recently received a funding of $388-million from the Coalition for Epidemic Preparedness Innovation, making it the biggest investment ever from the group. Dr. Gregory Glenn, Novavax’s president of…

Published

on

May.14 — Novavax Inc.’s vaccine is one of at least 100 potential candidates trying to curb the spread of the virus that causes Covid-19. The biotech company recently received a funding of $388-million from the Coalition for Epidemic Preparedness Innovation, making it the biggest investment ever from the group. Dr. Gregory Glenn, Novavax’s president of research and development, speaks on “Bloomberg Technology.”

Continue Reading
Advertisement
12 Comments

12 Comments

  1. 270360 270360

    May 14, 2020 at 11:39 pm

    The good Novavax Inc.s will help humanity and here is some interesting , (here is kid’s opinion). God bless our leaders for taking care of us all!

  2. Altamash

    May 15, 2020 at 12:26 am

    Is it potential vaccine or actually curable?

  3. Dhiraj khatri

    May 15, 2020 at 2:04 am

    nice

  4. Voltaire

    May 15, 2020 at 2:19 am

    But will it be approved by the end of the year?

  5. carlos blandino

    May 15, 2020 at 3:12 am

    I bought this company for $20 a share 3 days ago. It already went up to $40 s share. Thanks Novavak for making me money.

    • Cao Minh Duc

      May 17, 2020 at 3:26 am

      It’s not Novavax that made you the money, it’s the senseless stock speculators that gave you that money. Vaccine development is an extremely unpredictable process. Far more failures than successes. Yet we have seen biotech companies that double, triple in value since they release several “news” on their Covid 19 related vaccine works.

  6. Michael Weinberg

    May 15, 2020 at 3:57 am

    There is NO need for a COVID vaccine. Here is Proof presented before US The Senate that IV Vitamin C in cocktail is HIghly successful in SAFELY treating COVID 19: @. YES SAFELY!

    • ajay g

      May 15, 2020 at 9:33 am

      What?

    • Mothra J Disco

      May 15, 2020 at 9:43 am

      ajay g Pseudoscience people just ignore

      Same people who think B-17 is a cure for cancer

  7. Joe Bloe

    May 15, 2020 at 5:36 am

    How about some transparency from Emily Chang — like who’s paying you to trash Tesla, what started your hatred rampage against men, and when are you going to learn how to dress like a woman instead of an awkward teenager?

    • hmad_wesk 99

      May 15, 2020 at 7:23 am

      When will you stop peeing in your own pants?????

  8. Rosa G. The Truth Hurtz

    May 17, 2020 at 1:22 am

    These assholes are making billions while striping away civil liberties smh

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Oura CMO Says Wearable Health Tracking Moving Beyond Checkups

Oura’s Chief Medical Officer suggests wearable tech could give people a continuous picture of their health, rather than relying on occasional doctor visits. Dr. Ricky Bloomfield says the constant stream of health data provided to users of wearables, like Oura’s smart rings, can improve health outcomes and influence behavior. He says the long-term goal is…

Published

on

Oura’s Chief Medical Officer suggests wearable tech could give people a continuous picture of their health, rather than relying on occasional doctor visits.
Dr. Ricky Bloomfield says the constant stream of health data provided to users of wearables, like Oura’s smart rings, can improve health outcomes and influence behavior. He says the long-term goal is to help spot changes earlier and connect people with care sooner. Bloomfield spoke to Tom Mackenzie on the latest episode of “Bloomberg Tech: Europe.”
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

OpenAI’s $70B Run Rate Meets AI’s Infrastructure Challenge

loomberg’s Ed Ludlow breaks down OpenAI’s latest annualized revenue, expected to reach or exceed $70 billion by the end of the year. Plus, Oracle keeps several data centers on track by relying on truck deliveries of natural gas, and a conversation with Kleiner Perkins partner Ilya Fushman on the mega AI IPO pipeline and the…

Published

on

loomberg’s Ed Ludlow breaks down OpenAI’s latest annualized revenue, expected to reach or exceed $70 billion by the end of the year. Plus, Oracle keeps several data centers on track by relying on truck deliveries of natural gas, and a conversation with Kleiner Perkins partner Ilya Fushman on the mega AI IPO pipeline and the future of physical AI.

Chapters:
00:00:00 – Bloomberg Tech Begins
00:01:29 – Bloomberg’s Rebecca Torrence on OpenAI seeing $70B Revenue Run Rate by Year-End
00:05:02 – Michelle Weaver, Morgan Stanley US Thematic Research Strategist
00:11:12 – Wall Street Week: AI Spending Tests Debt Markets
00:14:16 – Bloomberg’s Brody Ford Discusses Oracle Trucking Gas to Keep Data Centers on Track
00:16:52 – Hiba Anver, Erickson Immigration Group Partner
00:23:14 – Ilya Fushman, Kleiner Perkins Partner
00:39:02 – Talking Tech with Yahaira Anand
00:41:08 – Bloomberg’s Nina Trentmann Reports on AI Spending Worrying CFO’s
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

From Anthropic to Waymo: Kleiner Perkins Bets on AI’s Next Act

Kleiner Perkins partner Ilya Fushman says AI is still in the early stages of reshaping the economy, with opportunities extending from frontier models like Anthropic to consumer agents, autonomous vehicles and robotics. He discusses why the firm sees physical AI as a potential source of the next trillion-dollar companies, the rapid growth of leading private…

Published

on

Kleiner Perkins partner Ilya Fushman says AI is still in the early stages of reshaping the economy, with opportunities extending from frontier models like Anthropic to consumer agents, autonomous vehicles and robotics. He discusses why the firm sees physical AI as a potential source of the next trillion-dollar companies, the rapid growth of leading private AI businesses, and why he’s increasingly optimistic about both the IPO and M&A markets. He joins Ed Ludlow on “Bloomberg Tech.”
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending